Chronic Lyme disease treatments tied to serious adverse effects

June 20, 2017

(HealthDay)—Serious bacterial infections have been documented during treatment for chronic Lyme disease, according to research published in the June 16 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that chronic Lyme disease is used by some as a diagnosis for constitutional, musculoskeletal, and , Natalie S. Marzec, M.D., from the University of Colorado in Aurora, and colleagues address the issue of serious bacterial infections during treatments for chronic Lyme disease, detailing five illustrative cases.

The authors note that patients with a diagnosis of chronic Lyme disease are treated with a wide range of medications, including long courses of intravenous antibiotics. These treatments have not been shown to result in substantial long-term improvement, and they can be harmful. Cases of septic shock, osteomyelitis, Clostridium difficile colitis, and paraspinal abscess have been documented as a result of chronic Lyme disease treatments.

"Patients, clinicians, and public health practitioners should be aware that treatments for chronic Lyme disease can carry serious risks," the authors write.

Explore further: No Lyme disease in Australia, new research finds

More information: Abstract/Full Text

Related Stories

No Lyme disease in Australia, new research finds

October 31, 2016
Lyme disease cannot be contracted in Australia and patients should not be treated with antibiotics for so-called Lyme-like diseases, new medical research has found.

Lyme disease 'Biofilm' eludes antibiotics: report

February 25, 2016
(HealthDay)—The bacteria that causes Lyme disease protects itself from antibiotics by forming a slime-like layer called a biofilm, a new study shows.

New national Lyme Disease biobank to accelerate research by making samples available

January 24, 2017
Bay Area Lyme Foundation, a national organization funding research to make Lyme disease easy to diagnose and simple to cure, announces the launch of the Lyme Disease Biobank, which is the first program to provide researchers ...

New Lyme disease estimate: 300,000 cases a year

August 19, 2013
Health officials say Lyme disease is about 10 times more common than previously reported.

Gene signature could lead to a new way of diagnosing Lyme

February 12, 2016
Researchers at UC San Francisco and Johns Hopkins may have found a new way to diagnose Lyme disease, based on a distinctive gene "signature" they discovered in white blood cells of patients infected with the tick-borne bacteria.

Recommended for you

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

Polio: Environmental monitoring will be key as world reaches global eradication

October 15, 2018
Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, ...

Study traces hospital-acquired bloodstream infections to patients' own bodies

October 15, 2018
The most common source of a bloodstream infection acquired during a hospital stay is not a nurse's or doctor's dirty hands, or another patient's sneeze or visitor's cough, but the patient's own gut, Stanford University School ...

Researchers make essential imaging tests safer for people at risk of acute kidney injury

October 15, 2018
Every year, millions of people undergo medical tests and procedures, such as coronary angiography, which use intravascular contrast dyes. "For the majority of patients, these are safe and necessary procedures. However, about ...

Medical marijuana might help MS patients, but uncertainty remains

October 13, 2018
Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients.

Do not give decongestants to young children for common cold symptoms, say experts

October 11, 2018
Decongestants should not be given to children under 6—and given with caution in children under 12—as there is no evidence that they alleviate symptoms such as a blocked or runny nose, and their safety is unclear, say ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.